Arca Biopharma | ABIO - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.68B 40M 2026-09
Arca Biopharma USD 2.23M 1.08M 2025-12
Biogen USD 752M 42.3M 2026-09
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 113.14M 8.75M 2026-09
Daiichi Sankyo JPY 237.75B 12.21B 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Grifols EUR 320.45M 12.65M 2025-12
Laboratory Of America USD 611.4M 34.2M 2026-09
Myriad Genetics USD 122.3M 6.7M 2025-12
Otsuka Holdings JPY 281.85B 7.41B 2026-09
Pfizer USD 3.28B 132M 2026-09
United Therapeutics USD 184.1M 22.6M 2026-09